These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2788754)

  • 1. [An immune adjuvant activity of mycolic acid-containing glycolipid, trehalose-2,3,6'-trimycolate, derived from Gordona aurantiaca].
    Ohtsubo Y; Furukawa M; Fujinobu Y; Sugimoto N; Ikutoh M; Katoh Y; Yano I; Higasa M; Shinka S; Dohi Y
    Nihon Saikingaku Zasshi; 1989 Mar; 44(2):533-9. PubMed ID: 2788754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro activation of immune cells by a mycolic acid-containing glycolipid, trehalose-2,3,6'-trimycolate, derived from Gordona aurantiaca].
    Ohtsubo Y; Furukawa M; Sugimoto N; Ikutoh M; Katoh Y; Yano I; Shinka S; Dohi Y
    Nihon Saikingaku Zasshi; 1989 Nov; 44(6):797-803. PubMed ID: 2533624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tumoricidal activated macrophages by a liposome-encapsulated glycolipid, trehalose 2,3,6'-trimycolate from Gordona aurantiaca.
    Furukawa M; Ohtsubo Y; Sugimoto N; Katoh Y; Dohi Y
    FEMS Microbiol Immunol; 1990 Sep; 2(2):83-8. PubMed ID: 2257164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of interferons (IFNs) and tumor necrosis factor (TNF) in mice by a novel glycolipid trehalose 2,3,6'-trimycolate from Rhodococcus aurantiacus (Gordona aurantiaca).
    Fujita T; Sugimoto N; Yokoi F; Ohtsubo Y; Ikutoh M; Kato Y; Natsuhara Y; Oka S; Yano I
    Microbiol Immunol; 1990; 34(6):523-32. PubMed ID: 1699114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of tumour cells by a liposome-encapsulated, mycolic acid-containing glycolipid, trehalose 2,3,6'-trimycolate.
    Ohtsubo Y; Furukawa M; Imagawa T; Sugimoto N; Ikutoh M; Nakatsugi S; Katoh Y; Shinka S; Dohi Y
    Immunology; 1991 Nov; 74(3):497-503. PubMed ID: 1769697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous gamma interferon is essential in granuloma formation induced by glycolipid-containing mycolic acid in mice.
    Asano M; Nakane A; Minagawa T
    Infect Immun; 1993 Jul; 61(7):2872-8. PubMed ID: 8514390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
    Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
    Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of natural killer cell activation and antibody-dependent cellular cytotoxicity by interferon-alpha and interleukin-12 in vaginal mucosae Sivmac251-infected Macaca fascicularis.
    Poaty-Mavoungou V; Touré FS; Tevi-Benissan C; Mavoungou E
    Viral Immunol; 2002; 15(1):197-212. PubMed ID: 11952142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.
    Cooley S; Burns LJ; Repka T; Miller JS
    Exp Hematol; 1999 Oct; 27(10):1533-41. PubMed ID: 10517495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of cellular immune response by Ipomoea obscura and Ipobscurine alkaloid attenuates tumor growth in mice.
    Hamsa TP; Kuttan G
    Can J Physiol Pharmacol; 2011 Apr; 89(4):259-68. PubMed ID: 21539469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Granuloma formation in mice by liposomes of new glycolipid containing mycolic acids, "trehalose 2,3,6'-trimycolate"].
    Yokoi F; Sugimoto N; Kato K; Kaneda K; Oka S; Yano I
    Yakugaku Zasshi; 1989 Jan; 109(1):46-51. PubMed ID: 2732903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth.
    Takayama T; Tahara H; Thomson AW
    Transplantation; 2001 May; 71(9):1334-40. PubMed ID: 11397973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target cell-directed inactivation and IL-2-dependent reactivation of LAK cells.
    Xiao J; Brahmi Z
    Cell Immunol; 1989 Sep; 122(2):295-306. PubMed ID: 2788512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
    Lauwerys BR; Garot N; Renauld JC; Houssiau FA
    J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines.
    Roda JM; Joshi T; Butchar JP; McAlees JW; Lehman A; Tridandapani S; Carson WE
    Clin Cancer Res; 2007 Nov; 13(21):6419-28. PubMed ID: 17962339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.